Videos

Karla Palmer, director at Hyman, Phelps, & McNamara, discusses how the Hemp Farming Act of 2018 affected hemp and CBD products.

Calvin Knowlton, BSc Pharm, MDiv, PhD, and CEO, Chairman, & Founder of Tabula Rasa Healthcare, discusses how pharmacists should approach adverse drug events and reactions to better help their patients.

Ron Lanton III, Esq., discusses the specialty pharmacist's role in educating patients about biosimilars and biologics.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Ron Lanton III, Esq., discusses challenges in launching biosimilars after they've been approved.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Suzy Soliman, PharmD, founder of the Pharmacist Moms Group, discusses how Cardinal Health has supported Women Pharmacist Day.

Suzy Soliman, PharmD, discusses why October 12 was chosen to recognize Women Pharmacist Day.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

At the ESMO Congress 2019, Ulrik Lassen, MD, PhD, professor of oncology at the University of Copenhagen, discussed the newly-released clinical data highlighting new overall survival and progression-free survival results for larotrectinib (Vitrakvi, Bayer) in tropomyosin receptor kinase (TRK) fusion cancer.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.